{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:19:57Z","timestamp":1783005597181,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolically healthy non-obese (MHN) individuals are considered at low cardiometabolic risk, yet a subset may harbor unfavorable visceral adiposity not captured by conventional anthropometric measures, including waist circumference (WC) and BMI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a prospective cohort study of 22,040 UK Biobank participants (median follow-up 4.2\u00a0years [interquartile range 3.4\u20135.6]) defined as MHN (BMI\u2009&lt;\u200930\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , absence of diabetes or concurrent hypertension and hyperlipidemia). Visceral (VAT) and subcutaneous adipose tissue (SAT) volumes were quantified from whole-body MRI using a validated deep learning framework. Sex-specific VAT\/SAT ratio cutoffs were derived from the German National Cohort based on prevalent cardiometabolic disease and applied to the UK Biobank. The primary outcome was incident major adverse cardiovascular events (MACE); the secondary outcome was incident type 2 diabetes. Categorical net reclassification improvement (NRI), quantifying the net proportion of individuals correctly reclassified between predefined risk categories, compared VAT\/SAT ratio versus WC as competing classification approaches. Cox proportional hazards models assessed associations with outcomes after stepwise adjustment for age, sex, smoking, WC, and BMI. Nested models with and without VAT\/SAT ratio were compared to test for added value beyond other factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The VAT\/SAT ratio improved risk classification over WC for MACE (NRI 0.088, 95%CI 0.019\u20130.158,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013) and diabetes (NRI 0.102, 95% CI 0.024\u20130.181,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.010). High VAT\/SAT ratio independently predicted MACE (adjusted hazard ratio [aHR] 1.30, 95%CI 1.02\u20131.66,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.037) and diabetes (aHR 1.77, 95% CI 1.34\u20132.33,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) after full adjustment. Adding VAT\/SAT to fully adjusted models improved discrimination for MACE (C-index 0.694 vs. 0.690,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036) and diabetes (C-index 0.723 vs. 0.715,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The VAT\/SAT ratio identifies MHN individuals at elevated cardiometabolic risk beyond conventional anthropometric measures, with particularly strong associations for incident diabetes. These findings support the concept of opportunistic imaging-based risk assessment and provide the prognostic foundation for future trials investigating whether targeted intervention in VAT\/SAT-reclassified individuals improves outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-026-03265-2","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:26:23Z","timestamp":1782933983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Opportunistic screening for incident cardiometabolic disease in metabolically healthy non-obese individuals: a prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Bal\u00e1zs","family":"Bogner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Reisert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Maushagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Rospleszcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kroencke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Pischon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Schulz-Menger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoralf","family":"Niendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Schlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Bamberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Taron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"21","key":"3265_CR1","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American heart association. Circulation. 2021;143(21):e984\u20131010.","journal-title":"Circulation"},{"issue":"10440","key":"3265_CR2","first-page":"2100","volume":"403","author":"Collaborators GBDCoD","year":"1990","unstructured":"Collaborators GBDCoD. Life expectancy in Asian Countries 1990\u20132021: a subanalysis of causes and risk factors from the global burden of disease study 2021. Lancet. 1990;403(10440):2100\u201332.","journal-title":"Lancet"},{"issue":"3","key":"3265_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3265_CR4","doi-asserted-by":"publisher","first-page":"1411678","DOI":"10.3389\/fendo.2024.1411678","volume":"15","author":"C Torun","year":"2024","unstructured":"Torun C, Ankarali H, Castur L, et al. Prediction of visceral adipose tissue magnitude using a new model based on simple clinical measurements. Front Endocrinol (Lausanne). 2024;15:1411678.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3265_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105467","volume":"110","author":"M Jung","year":"2024","unstructured":"Jung M, Raghu VK, Reisert M, et al. Deep learning-based body composition analysis from whole-body magnetic resonance imaging to predict all-cause mortality in a large western population. EBioMedicine. 2024;110:105467.","journal-title":"EBioMedicine"},{"issue":"9","key":"3265_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despres JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715\u201325.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"3265_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1748-1716.2012.02409.x","volume":"205","author":"A Wronska","year":"2012","unstructured":"Wronska A, Kmiec Z. Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol (Oxf). 2012;205(2):194\u2013208.","journal-title":"Acta Physiol (Oxf)"},{"issue":"12","key":"3265_CR8","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2021e11521","volume":"54","author":"WF Pereira-Manfro","year":"2021","unstructured":"Pereira-Manfro WF, Lima GR, Nogueira Neto JF, et al. Association between visceral\/subcutaneous adipose tissue ratio and plasma inflammatory markers and score for cardiovascular risk prediction in a Brazilian cohort: Pro-Saude Study. Braz J Med Biol Res. 2021;54(12):e11521.","journal-title":"Braz J Med Biol Res"},{"issue":"7","key":"3265_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.numecd.2020.03.017","volume":"30","author":"K Okada","year":"2020","unstructured":"Okada K, Hibi K, Honda Y, Fitzgerald PJ, Tamura K, Kimura K. Association between abdominal fat distribution and coronary plaque instability in patients with acute coronary syndrome. Nutr Metab Cardiovasc Dis. 2020;30(7):1169\u201378.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1089","key":"3265_CR10","doi-asserted-by":"publisher","first-page":"20170808","DOI":"10.1259\/bjr.20170808","volume":"91","author":"C Storz","year":"2018","unstructured":"Storz C, Heber SD, Rospleszcz S, et al. The role of visceral and subcutaneous adipose tissue measurements and their ratio by magnetic resonance imaging in subjects with prediabetes, diabetes and healthy controls from a general population without cardiovascular disease. Br J Radiol. 2018;91(1089):20170808.","journal-title":"Br J Radiol"},{"issue":"1","key":"3265_CR11","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1186\/s12889-024-19358-0","volume":"24","author":"H Emamat","year":"2024","unstructured":"Emamat H, Jamshidi A, Farhadi A, Ghalandari H, Ghasemi M, Tangestani H. The association between the visceral to subcutaneous abdominal fat ratio and the risk of cardiovascular diseases: a systematic review. BMC Public Health. 2024;24(1):1827.","journal-title":"BMC Public Health"},{"issue":"3","key":"3265_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"6","key":"3265_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2217\/14622416.6.6.639","volume":"6","author":"W Ollier","year":"2005","unstructured":"Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality. Pharmacogenomics. 2005;6(6):639\u201346.","journal-title":"Pharmacogenomics"},{"issue":"9","key":"3265_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163332","volume":"11","author":"J West","year":"2016","unstructured":"West J, Dahlqvist Leinhard O, Romu T, et al. Feasibility of MR-Based Body Composition Analysis in Large Scale Population Studies. PLoS ONE. 2016;11(9):e0163332.","journal-title":"PLoS ONE"},{"issue":"4","key":"3265_CR15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.2337\/dc20-1760","volume":"44","author":"AA Kammerlander","year":"2021","unstructured":"Kammerlander AA, Mayrhofer T, Ferencik M, et al. Association of metabolic phenotypes with coronary artery disease and cardiovascular events in patients with stable chest pain. Diabetes Care. 2021;44(4):1038\u201345.","journal-title":"Diabetes Care"},{"issue":"10","key":"3265_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10654-022-00890-5","volume":"37","author":"A Peters","year":"2022","unstructured":"Peters A, German National Cohort C, Peters A, et al. Framework and baseline examination of the German National Cohort (NAKO). Eur J Epidemiol. 2022;37(10):1107\u201324.","journal-title":"Eur J Epidemiol"},{"issue":"13","key":"3265_CR17","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jacc.2018.08.1037","volume":"72","author":"CJ Lavie","year":"2018","unstructured":"Lavie CJ, Laddu D, Arena R, Ortega FB, Alpert MA, Kushner RF. Healthy weight and obesity prevention: JACC health promotion series. J Am Coll Cardiol. 2018;72(13):1506\u201331.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"3265_CR18","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1007\/s00125-012-2639-5","volume":"55","author":"BM Kaess","year":"2012","unstructured":"Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55(10):2622\u201330.","journal-title":"Diabetologia"},{"issue":"11","key":"3265_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019968","volume":"10","author":"AA Kammerlander","year":"2021","unstructured":"Kammerlander AA, Lyass A, Mahoney TF, et al. Sex differences in the associations of visceral adipose tissue and cardiometabolic and cardiovascular disease risk: the framingham heart study. J Am Heart Assoc. 2021;10(11):e019968.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"3265_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.004043","volume":"9","author":"AL Figueroa","year":"2016","unstructured":"Figueroa AL, Takx RA, MacNabb MH, et al. relationship between measures of adiposity, arterial inflammation, and subsequent cardiovascular events. Circ Cardiovasc Imaging. 2016;9(4):e004043.","journal-title":"Circ Cardiovasc Imaging"},{"key":"3265_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2016.06.041","volume":"251","author":"A Kunimura","year":"2016","unstructured":"Kunimura A, Ishii H, Uetani T, et al. Impact of adipose tissue composition on cardiovascular risk assessment in patients with stable coronary artery disease. Atherosclerosis. 2016;251:206\u201312.","journal-title":"Atherosclerosis"},{"issue":"12","key":"3265_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226642","volume":"14","author":"Y Miura","year":"2019","unstructured":"Miura Y, Higuchi S, Matsushita K, et al. Clinical impact of visceral-to-subcutaneous fat ratio in patients with acute aortic dissection. PLoS ONE. 2019;14(12):e0226642.","journal-title":"PLoS ONE"},{"issue":"5","key":"3265_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.recesp.2016.09.006","volume":"70","author":"R Ladeiras-Lopes","year":"2017","unstructured":"Ladeiras-Lopes R, Sampaio F, Bettencourt N, et al. The ratio between visceral and subcutaneous abdominal fat assessed by computed tomography is an independent predictor of mortality and cardiac events. Rev Esp Cardiol (Engl Ed). 2017;70(5):331\u20137.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"3","key":"3265_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","volume":"120","author":"AK Boehme","year":"2017","unstructured":"Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472\u201395.","journal-title":"Circ Res"},{"issue":"2","key":"3265_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014402","volume":"9","author":"B Miao","year":"2020","unstructured":"Miao B, Hernandez AV, Alberts MJ, Mangiafico N, Roman YM, Coleman CI. Incidence and predictors of major adverse cardiovascular events in patients with established atherosclerotic disease or multiple risk factors. J Am Heart Assoc. 2020;9(2):e014402.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"3265_CR26","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.numecd.2024.04.001","volume":"34","author":"D Deng","year":"2024","unstructured":"Deng D, Nie Z, Wang J, et al. Association between metabolic phenotypes of overweight\/obesity and cardiovascular diseases in postmenopausal women. Nutr Metab Cardiovasc Dis. 2024;34(11):2562\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"3265_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12020-025-04169-z","volume":"88","author":"R Xu","year":"2025","unstructured":"Xu R, Wang C, Cong H, Wang L. Association of metabolic phenotypes with cardiovascular events in patients aged 18\u201345 with acute coronary syndrome. Endocrine. 2025;88(2):457\u201366.","journal-title":"Endocrine"},{"key":"3265_CR28","doi-asserted-by":"crossref","unstructured":"Bluher M. Metabolically Healthy Obesity. Endocr Rev. 2020;41(3).","DOI":"10.1210\/endrev\/bnaa004"},{"issue":"5","key":"3265_CR29","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222044","volume":"307","author":"PJ Pickhardt","year":"2023","unstructured":"Pickhardt PJ, Summers RM, Garrett JW, et al. Opportunistic screening: radiology scientific expert panel. Radiology. 2023;307(5):e222044.","journal-title":"Radiology"},{"issue":"11","key":"3265_CR30","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.7326\/ANNALS-24-01863","volume":"178","author":"M Jung","year":"2025","unstructured":"Jung M, Reisert M, Rieder H, et al. Association between body composition and cardiometabolic outcomes\u202f: a prospective cohort study. Ann Intern Med. 2025;178(11):1561\u201370.","journal-title":"Ann Intern Med"},{"issue":"9","key":"3265_CR31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026\u201334.","journal-title":"Am J Epidemiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03265-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03265-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03265-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:05:02Z","timestamp":1783004702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03265-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3265"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03265-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted under the UKB\u2019s general ethical approval from the NHS National Research Ethics Service. All UKB participants provided written informed consent at enrollment. Informed consent was also obtained from all participants in the NAKO. In addition, local IRB approval was received from the University of Freiburg (IRB numbers: 23\u20131316-S1-retro and 24\u20131099-S1-retro).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"CLS: Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events: Siemens Healthineers, Bayer Healthcare. FB: Grants or contracts from any entity: Siemens Healthineers, Bayer Healthcare. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Siemens Healthineers, Bayer Healthcare. JT: Consulting fees: Onc.AI. JW: Consulting fees: Onc.AI.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"190"}}